세계 의약품 블리스터 포장 시장 : 재료별, 기술별, 제품별, 용도별, 최종사용자별, 지역별 - 동향 분석, 경쟁 구도, 예측(2019-2030년)

Global Pharmaceutical Blister Packaging Market Poised to Reach USD 13.7 Billion by 2030

Global Pharmaceutical Blister Packaging Market is flourishing because of the rising demand for convenience and child-resistant packaging and advancements in packaging technologies.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated Global Pharmaceutical Blister Packaging Market size at USD 8.7 billion in 2023. During the forecast period between 2024 and 2030, BlueWeave expects Global Pharmaceutical Blister Packaging Market size to expand at a CAGR of 6.90% reaching a value of USD 13.7 billion by 2030. Major growth factors for Global Pharmaceutical Blister Packaging Market include growing pharmaceutical sector as a result of the rising incidence of chronic illnesses and the advantages this packaging provides, such as cost-effectiveness, dosage precision, and tamper evidence. Additionally, it is projected that throughout the forecast period, Global Pharmaceutical Blister Packaging Market would be driven by technological integration, such as the incorporation of sensors or other tracking technologies into the package.

Opportunity - Technology Integration in Blister Packaging

The rising adoption of technological advancements in blister packaging, such as integration of sensors and microprocessors, is projected to provide lucrative growth opportunities to players in Global Pharmaceutical Blister Packaging Market. According to a study published on National Center for Biotechnology Information, electronic smart blister packages facilitates medication tracking through medication tracking through reminders sent to their mobile phones. With expanding demand for smart blister packaging, Schreiner MediPharm has developed a smart blister packaging for oral solid dose medication equipped with state of art technology for digital adherence monitoring.

Impact of Escalating Geopolitical Tensions on Global Pharmaceutical Blister Packaging Market

Intensifying geopolitical tensions may pose significant challenges for the growth of Global Pharmaceutical Blister Packaging Market. Geopolitical conflicts interrupt supply chains and result in shortages of raw materials and vital components, including PVC, paper, aluminum, and other packaging materials, utilized in the pharmaceutical blister packaging sector. Many of the materials used in pharmaceutical packaging must be imported from other nations. Political unrest and trade barriers like tariffs and sanctions, however, may result in delays or higher packaging material costs. Additionally, these conflicts can make pharmaceutical corporations reevaluate where they produce their goods and packaging. Businesses may relocate their activities away from areas with high levels of volatility in order to prevent interruptions.

Tablet Segment to Grow at Fastest CAGR

Due to its high demand in the pharmaceutical industry, the tablet segment holds the largest share of Global Pharmaceutical Blister Packaging Market. Many pharmaceutical companies choose tablets as the dosage form for their products, which helps them grow their market share. Tablets are preferred over other oral drug forms because of their durability and longer shelf life, as well as the fact that they can be produced using a variety of techniques, including wet or dry granulation, and have lower production costs.

North America Holds Major Market Share

North America dominates Global Pharmaceutical Blister Packaging Market. The demand for pharmaceutical blister packaging in the region is fueled by the significant concentration of major pharmaceutical firms, including Johnson & Johnson, Abbott Laboratories, Pfizer, and Bristol-Myers Squibb. In the United States, pharmaceutical packaging is governed by the Food and Drug Administration (FDA). It establishes guidelines like the usage of tamper-evident packaging for over-the-counter medications, which propels the expansion of United States Pharmaceutical Blister Packaging Market.

Competitive Landscape

Major players in Global Pharmaceutical Blister Packaging market include Amcor, Constantia Flexibles, WestRock Company, Klockner Pentaplast, Honeywell International, Sonoco Products Company, RENOLIT SE, Winpak Ltd, Uflex Ltd, ACG Pharmapack Pvt Ltd, and Tekni-Plex, Inc. The presence of high number of companies intensify the market competition as they compete to gain a significant market share.

These companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches to further enhance their market share.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and Global Pharmaceutical Blister Packaging Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Pharmaceutical Blister Packaging Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

• 1.1. Research Objective
• 1.2. Product Overview
• 1.3. Market Segmentation

2. Executive Summary

3. Global Pharmaceutical Blister Packaging Market Insights

• 3.1. Industry Value Chain Analysis
• 3.2. DROC Analysis
  • 3.2.1. Growth Drivers
    • 3.2.1.1. Rising Demand for Convenience and Child-Resistant Packaging
    • 3.2.1.2. Growing Geriatric Population
    • 3.2.1.3. Advancements in Packaging Technologies
  • 3.2.2. Restraints
    • 3.2.2.1. Environmental Concerns and Sustainability
    • 3.2.2.2. High Initial Investment Costs
  • 3.2.3. Opportunities
    • 3.2.3.1. Increasing Focus on Brand Differentiation
    • 3.2.3.2. Growing E-commerce and Online Pharmacies
  • 3.2.4. Challenges
    • 3.2.4.1. Potential for Product Damage and Tampering
    • 3.2.4.2. Regulatory Hurdles and Compliance Costs
• 3.3. Technological Advancements/Recent Developments
• 3.4. Regulatory Framework
• 3.5. Porter's Five Forces Analysis
  • 3.5.1. Bargaining Power of Suppliers
  • 3.5.2. Bargaining Power of Buyers
  • 3.5.3. Threat of New Entrants
  • 3.5.4. Threat of Substitutes
  • 3.5.5. Intensity of Rivalry

4. Global Pharmaceutical Blister Packaging Market: Marketing Strategies

5. Global Pharmaceutical Blister Packaging Market Overview

• 5.1. Market Size & Forecast, 2019-2030
  • 5.1.1. By Value (USD Billion)
• 5.2. Market Share & Forecast
  • 5.2.1. By Material
    • 5.2.1.1. Plastic Films
    • 5.2.1.2. Aluminum Foil
    • 5.2.1.3. Paper & Paperboard
    • 5.2.1.4. Others (Composites, Bioplastics, etc.)
  • 5.2.2. By Technology
    • 5.2.2.1. Cold Forming
    • 5.2.2.2. Thermoforming
    • 5.2.2.3. Heat Sealing
  • 5.2.3. By Product
    • 5.2.3.1. Standard Blisters
    • 5.2.3.2. Clamshells
    • 5.2.3.3. Combination Packs
    • 5.2.3.4. Customized Blisters
  • 5.2.4. By Application
    • 5.2.4.1. Tablets
    • 5.2.4.2. Capsules
    • 5.2.4.3. Ampoules and Vials
    • 5.2.4.4. Syringes
    • 5.2.4.5. Other
  • 5.2.5. By End User
    • 5.2.5.1. Pharmaceutical Companies
    • 5.2.5.2. Contract Packaging Manufacturers
    • 5.2.5.3. Hospitals and Clinics
  • 5.2.6. By Region
    • 5.2.6.1. North America
    • 5.2.6.2. Europe
    • 5.2.6.3. Asia Pacific (APAC)
    • 5.2.6.4. Latin America (LATAM)
    • 5.2.6.5. Middle East and Africa (MEA)

6. North America Pharmaceutical Blister Packaging Market

• 6.1. Market Size & Forecast, 2019-2030
  • 6.1.1. By Value (USD Billion)
• 6.2. Market Share & Forecast
  • 6.2.1. By Material
  • 6.2.2. By Technology
  • 6.2.3. By Product
  • 6.2.4. By Application
  • 6.2.5. By End User
  • 6.2.6. By Country
    • 6.2.6.1. United States
    • 6.2.6.1.1. By Material
    • 6.2.6.1.2. By Technology
    • 6.2.6.1.3. By Product
    • 6.2.6.1.4. By Application
    • 6.2.6.1.5. By End User
    • 6.2.6.2. Canada
    • 6.2.6.2.1. By Material
    • 6.2.6.2.2. By Technology
    • 6.2.6.2.3. By Product
    • 6.2.6.2.4. By Application
    • 6.2.6.2.5. By End User

7. Europe Pharmaceutical Blister Packaging Market

• 7.1. Market Size & Forecast, 2019-2030
  • 7.1.1. By Value (USD Billion)
• 7.2. Market Share & Forecast
  • 7.2.1. By Material
  • 7.2.2. By Technology
  • 7.2.3. By Product
  • 7.2.4. By Application
  • 7.2.5. By End User
  • 7.2.6. By Country
    • 7.2.6.1. Germany
    • 7.2.6.1.1. By Material
    • 7.2.6.1.2. By Technology
    • 7.2.6.1.3. By Product
    • 7.2.6.1.4. By Application
    • 7.2.6.1.5. By End User
    • 7.2.6.2. United Kingdom
    • 7.2.6.2.1. By Material
    • 7.2.6.2.2. By Technology
    • 7.2.6.2.3. By Product
    • 7.2.6.2.4. By Application
    • 7.2.6.2.5. By End User
    • 7.2.6.3. Italy
    • 7.2.6.3.1. By Material
    • 7.2.6.3.2. By Technology
    • 7.2.6.3.3. By Product
    • 7.2.6.3.4. By Application
    • 7.2.6.3.5. By End User
    • 7.2.6.4. France
    • 7.2.6.4.1. By Material
    • 7.2.6.4.2. By Technology
    • 7.2.6.4.3. By Product
    • 7.2.6.4.4. By Application
    • 7.2.6.4.5. By End User
    • 7.2.6.5. Spain
    • 7.2.6.5.1. By Material
    • 7.2.6.5.2. By Technology
    • 7.2.6.5.3. By Product
    • 7.2.6.5.4. By Application
    • 7.2.6.5.5. By End User
    • 7.2.6.6. Belgium
    • 7.2.6.6.1. By Material
    • 7.2.6.6.2. By Technology
    • 7.2.6.6.3. By Product
    • 7.2.6.6.4. By Application
    • 7.2.6.6.5. By End User
    • 7.2.6.7. Russia
    • 7.2.6.7.1. By Material
    • 7.2.6.7.2. By Technology
    • 7.2.6.7.3. By Product
    • 7.2.6.7.4. By Application
    • 7.2.6.7.5. By End User
    • 7.2.6.8. The Netherlands
    • 7.2.6.8.1. By Material
    • 7.2.6.8.2. By Technology
    • 7.2.6.8.3. By Product
    • 7.2.6.8.4. By Application
    • 7.2.6.8.5. By End User
    • 7.2.6.9. Rest of Europe
    • 7.2.6.9.1. By Material
    • 7.2.6.9.2. By Technology
    • 7.2.6.9.3. By Product
    • 7.2.6.9.4. By Application
    • 7.2.6.9.5. By End User

8. Asia Pacific Pharmaceutical Blister Packaging Market

• 8.1. Market Size & Forecast, 2019-2030
  • 8.1.1. By Value (USD Billion)
• 8.2. Market Share & Forecast
  • 8.2.1. By Material
  • 8.2.2. By Technology
  • 8.2.3. By Product
  • 8.2.4. By Application
  • 8.2.5. By End User
  • 8.2.6. By Country
    • 8.2.6.1. China
    • 8.2.6.1.1. By Material
    • 8.2.6.1.2. By Technology
    • 8.2.6.1.3. By Product
    • 8.2.6.1.4. By Application
    • 8.2.6.1.5. By End User
    • 8.2.6.2. India
    • 8.2.6.2.1. By Material
    • 8.2.6.2.2. By Technology
    • 8.2.6.2.3. By Product
    • 8.2.6.2.4. By Application
    • 8.2.6.2.5. By End User
    • 8.2.6.3. Japan
    • 8.2.6.3.1. By Material
    • 8.2.6.3.2. By Technology
    • 8.2.6.3.3. By Product
    • 8.2.6.3.4. By Application
    • 8.2.6.3.5. By End User
    • 8.2.6.4. South Korea
    • 8.2.6.4.1. By Material
    • 8.2.6.4.2. By Technology
    • 8.2.6.4.3. By Product
    • 8.2.6.4.4. By Application
    • 8.2.6.4.5. By End User
    • 8.2.6.5. Australia & New Zealand
    • 8.2.6.5.1. By Material
    • 8.2.6.5.2. By Technology
    • 8.2.6.5.3. By Product
    • 8.2.6.5.4. By Application
    • 8.2.6.5.5. By End User
    • 8.2.6.6. Indonesia
    • 8.2.6.6.1. By Material
    • 8.2.6.6.2. By Technology
    • 8.2.6.6.3. By Product
    • 8.2.6.6.4. By Application
    • 8.2.6.6.5. By End User
    • 8.2.6.7. Malaysia
    • 8.2.6.7.1. By Material
    • 8.2.6.7.2. By Technology
    • 8.2.6.7.3. By Product
    • 8.2.6.7.4. By Application
    • 8.2.6.7.5. By End User
    • 8.2.6.8. Singapore
    • 8.2.6.8.1. By Material
    • 8.2.6.8.2. By Technology
    • 8.2.6.8.3. By Product
    • 8.2.6.8.4. By Application
    • 8.2.6.8.5. By End User
    • 8.2.6.9. Vietnam
    • 8.2.6.9.1. By Material
    • 8.2.6.9.2. By Technology
    • 8.2.6.9.3. By Product
    • 8.2.6.9.4. By Application
    • 8.2.6.9.5. By End User
    • 8.2.6.10. Rest of APAC
    • 8.2.6.10.1. By Material
    • 8.2.6.10.2. By Technology
    • 8.2.6.10.3. By Product
    • 8.2.6.10.4. By Application
    • 8.2.6.10.5. By End User

9. Latin America Pharmaceutical Blister Packaging Market

• 9.1. Market Size & Forecast, 2019-2030
  • 9.1.1. By Value (USD Billion)
• 9.2. Market Share & Forecast
  • 9.2.1. By Material
  • 9.2.2. By Technology
  • 9.2.3. By Product
  • 9.2.4. By Application
  • 9.2.5. By End User
  • 9.2.6. By Country
    • 9.2.6.1. Brazil
    • 9.2.6.1.1. By Material
    • 9.2.6.1.2. By Technology
    • 9.2.6.1.3. By Product
    • 9.2.6.1.4. By Application
    • 9.2.6.1.5. By End User
    • 9.2.6.2. Mexico
    • 9.2.6.2.1. By Material
    • 9.2.6.2.2. By Technology
    • 9.2.6.2.3. By Product
    • 9.2.6.2.4. By Application
    • 9.2.6.2.5. By End User
    • 9.2.6.3. Argentina
    • 9.2.6.3.1. By Material
    • 9.2.6.3.2. By Technology
    • 9.2.6.3.3. By Product
    • 9.2.6.3.4. By Application
    • 9.2.6.3.5. By End User
    • 9.2.6.4. Peru
    • 9.2.6.4.1. By Material
    • 9.2.6.4.2. By Technology
    • 9.2.6.4.3. By Product
    • 9.2.6.4.4. By Application
    • 9.2.6.4.5. By End User
    • 9.2.6.5. Rest of LATAM
    • 9.2.6.5.1. By Material
    • 9.2.6.5.2. By Technology
    • 9.2.6.5.3. By Product
    • 9.2.6.5.4. By Application
    • 9.2.6.5.5. By End User

10. Middle East and Africa Pharmaceutical Blister Packaging Market

• 10.1. Market Size & Forecast, 2019-2030
  • 10.1.1. By Value (USD Billion)
• 10.2. Market Share & Forecast
  • 10.2.1. By Material
  • 10.2.2. By Technology
  • 10.2.3. By Product
  • 10.2.4. By Application
  • 10.2.5. By End User
  • 10.2.6. By Country
    • 10.2.6.1. Saudi Arabia
    • 10.2.6.1.1. By Material
    • 10.2.6.1.2. By Technology
    • 10.2.6.1.3. By Product
    • 10.2.6.1.4. By Application
    • 10.2.6.1.5. By End User
    • 10.2.6.2. UAE
    • 10.2.6.2.1. By Material
    • 10.2.6.2.2. By Technology
    • 10.2.6.2.3. By Product
    • 10.2.6.2.4. By Application
    • 10.2.6.2.5. By End User
    • 10.2.6.3. Qatar
    • 10.2.6.3.1. By Material
    • 10.2.6.3.2. By Technology
    • 10.2.6.3.3. By Product
    • 10.2.6.3.4. By Application
    • 10.2.6.3.5. By End User
    • 10.2.6.4. Kuwait
    • 10.2.6.4.1. By Material
    • 10.2.6.4.2. By Technology
    • 10.2.6.4.3. By Product
    • 10.2.6.4.4. By Application
    • 10.2.6.4.5. By End User
    • 10.2.6.5. South Africa
    • 10.2.6.5.1. By Material
    • 10.2.6.5.2. By Technology
    • 10.2.6.5.3. By Product
    • 10.2.6.5.4. By Application
    • 10.2.6.5.5. By End User
    • 10.2.6.6. Nigeria
    • 10.2.6.6.1. By Material
    • 10.2.6.6.2. By Technology
    • 10.2.6.6.3. By Product
    • 10.2.6.6.4. By Application
    • 10.2.6.6.5. By End User
    • 10.2.6.7. Algeria
    • 10.2.6.7.1. By Material
    • 10.2.6.7.2. By Technology
    • 10.2.6.7.3. By Product
    • 10.2.6.7.4. By Application
    • 10.2.6.7.5. By End User
    • 10.2.6.8. Rest of MEA
    • 10.2.6.8.1. By Material
    • 10.2.6.8.2. By Technology
    • 10.2.6.8.3. By Product
    • 10.2.6.8.4. By Application
    • 10.2.6.8.5. By End User

11. Competitive Landscape

• 11.1. List of Key Players and Their Offerings
• 11.2. Global Pharmaceutical Blister Packaging Company Market Share Analysis, 2023
• 11.3. Competitive Benchmarking, By Operating Parameters
• 11.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

12. Impact of Escalating Geopolitical Tension on Global Pharmaceutical Blister Packaging Market

13. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

• 13.1. Amcor
• 13.2. Constantia Flexibles
• 13.3. WestRock Company
• 13.4. Klockner Pentaplast
• 13.5. Honeywell International
• 13.6. Sonoco Products Company
• 13.7. RENOLIT SE
• 13.8. Winpak Ltd
• 13.9. Uflex Ltd
• 13.10. ACG Pharmapack Pvt Ltd
• 13.11. Tekni-Plex, Inc.
• 13.12. Other Prominent Players

14. Key Strategic Recommendations

15. Research Methodology

• 15.1. Qualitative Research
  • 15.1.1. Primary & Secondary Research
• 15.2. Quantitative Research
• 15.3. Market Breakdown & Data Triangulation
  • 15.3.1. Secondary Research
  • 15.3.2. Primary Research
• 15.4. Breakdown of Primary Research Respondents, By Region
• 15.5. Assumptions & Limitations

*Financial information of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable